Nevisense gains Australian approval

Report this content

SciBase has received clearance from the Thereapeutic Goods Administration (TGA) to commercialise Nevisense in Australia. Nevisense will be marketed in Australia and New Zealand by Equipmed, a leading independent distributor of devices in dermatology in the region.

Subscribe